TNXP
Tonix Pharmaceuticals Holding Corp.Company with tickers: TNXP
CIK
1430306
CUSIP
890260839
Shares Outstanding
15,940,801
Website
https://www.tonixpharma.com
Investor Relations
https://ir.tonixpharma.com/
13F Activity (30d)
4 filings
3 filers
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Seth Lederman | CEO | $3,168,830 |
| Jessica Morris | — | $1,226,269 |
| Gregory Sullivan | — | $1,216,542 |
| Bradley Saenger | CFO | $1,143,513 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Seth Lederman | CEO | $1,809,767 |
| Gregory Sullivan | — | $922,444 |
| Jessica Morris | — | $887,741 |
| Bradley Saenger | CFO | $849,981 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Seth Lederman | CEO | $2,050,065 |
| Gregory Sullivan | — | $951,998 |
| Jessica Morris | — | $928,599 |
| Bradley Saenger | CFO | $904,913 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Seth Lederman | CEO | $4,580,167 |
| Gregory Sullivan | — | $1,478,661 |
| Jessica Morris | — | $1,391,212 |
| Bradley Saenger | CFO | $1,236,430 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Seth Lederman | CEO | $7,708,389 |
| Gregory Sullivan | — | $2,247,785 |
| Bradley Saenger | CFO | $1,769,885 |
| Jessica Morris | — | $1,769,885 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Seth Lederman | CEO | $3,874,822 |
| Gregory Sullivan | — | $1,382,420 |
| Bradley Saenger | CFO | $1,091,808 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Seth Lederman | CEO | $1,288,273 |
| Gregory Sullivan | — | $652,393 |
| Bradley Saenger | CFO | $578,112 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Seth Lederman | CEO | $1,477,445 |
| Gregory Sullivan | — | $721,855 |
| Bradley Saenger | CFO | $616,235 |